Panbela Therapeutics, Inc. (PBLA)
OTCMKTS: PBLA · Delayed Price · USD
0.670
-0.005 (-0.71%)
Mar 28, 2024, 3:58 PM EDT - Market closed

Panbela Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Net Income
-25.26-34.93-10.14-4.77-6.2-5.91-10.37-5.11-4.93-0.11
Upgrade
Depreciation & Amortization
0000.112.07000.030.030.01
Upgrade
Share-Based Compensation
0.821.091.291.211.091.281.730.90.980
Upgrade
Other Operating Activities
-0.8118.572.14-0.410.32.245.241.780.030.09
Upgrade
Operating Cash Flow
-25.25-15.28-6.7-3.85-2.74-2.39-3.4-2.4-3.9-0.01
Upgrade
Capital Expenditures
0-0.6600000000
Upgrade
Acquisitions
0000000000
Upgrade
Change in Investments
---------0.5-
Upgrade
Other Investing Activities
0.4--0.54-----10.12
Upgrade
Investing Cash Flow
0.4-0.66-0.54000000.50.12
Upgrade
Common Stock Issued
1.65.359.0511.083.162.3301.871.510
Upgrade
Other Financing Activities
24.550.011.04-0.640.621.323.110.041.16-0.01
Upgrade
Financing Cash Flow
26.145.3510.110.443.783.643.111.922.68-0.01
Upgrade
Net Cash Flow
1.29-10.582.856.571.041.25-0.29-0.49-0.730.1
Upgrade
Free Cash Flow
-25.25-15.94-6.7-3.85-2.74-2.39-3.4-2.4-3.9-0.01
Upgrade
Free Cash Flow Margin
----------0.84%
Upgrade
Free Cash Flow Per Share
-232300.74-574.04-687.38-598.08-576.63-614.41-1145.07-926.23-3325.09-95.44
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.